How has been the historical performance of Kovai Medical?

Answer:The historical performance of Kovai Medical shows a consistent growth trajectory in net sales, with figures rising from 297.01 Cr in March 2013 to 585.51 Cr in March 2018. Other operating income also increased, albeit modestly, from 0.19 Cr in March 2012 to 6.85 Cr in March 2018. Total operating income followed a similar upward trend, reaching 592.37 Cr in March 2018. The total expenditure, excluding depreciation, rose from 226.17 Cr in March 2013 to 463.26 Cr in March 2018, reflecting increased operational costs. Operating profit, excluding other income, improved from 70.97 Cr in March 2013 to 129.11 Cr in March 2018, while the operating profit margin decreased slightly from 23.88% in March 2013 to 21.79% in March 2018. Profit before tax peaked at 89.44 Cr in March 2018, with profit after tax showing a slight decline to 57.98 Cr from 60.06 Cr in March 2017. The earnings per share (EPS) were 52.99 in March 2018, down from 54.89 in March 2017. Total assets grew significantly from 343.63 Cr in March 2013 to 606.12 Cr in March 2018, while total liabilities also increased from 343.63 Cr to 606.12 Cr in the same period. Cash flow from operating activities was 86.88 Cr in March 2018, with a net cash inflow of 23.98 Cr.

Breakdown:
Kovai Medical's financial performance over the years indicates a robust growth in net sales, which increased from 297.01 Cr in March 2013 to 585.51 Cr in March 2018. This growth in revenue was complemented by a rise in total operating income, which reached 592.37 Cr in March 2018. However, total expenditure also escalated, leading to a slight decrease in operating profit margin from 23.88% in March 2013 to 21.79% in March 2018. Despite fluctuations, profit before tax remained strong, peaking at 89.44 Cr in March 2018, while profit after tax saw a minor decline to 57.98 Cr. The company's total assets and liabilities both grew significantly, reflecting its expanding operations. Cash flow from operating activities remained positive, contributing to a net cash inflow of 23.98 Cr in March 2018, indicating healthy cash management amidst rising operational costs.